GENB in the 13F filings
Generate Biomedicines Inc · CUSIP 370920100
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 14 Aug 2026
- latest of these filings; the earliest 12 Aug 2026
- Managers listing it
- 11
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 2 listed it in both
- Shares listed
- 13,037,225
- combined, among listed positions
- Reported value
- $220m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 9 buyers (opened or added shares) and 8 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,143,058.
Managers listing GENB in Q2 2026
11 of 11 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 5,221,599 shares now+1,004,075
- ARK Investment Management LLCexisting position · 1,284,617 shares now+786,209
- Capital World Investorsexisting position · 4,215,632 shares now+211,483
- T. Rowe Price Associates Incexisting position · 2,156,627 shares now+46,994
- Renaissance Technologies LLCnew position · 39,685 shares now+39,685
Reductions
- Millennium Management LLCexisting position · 21,926 shares now-354,967
- Squarepoint Ops LLCexisting position · 31,406 shares now-5,797
New positions and exits
New (5)
Exited (6)
- ExodusPoint Capital Management LPwas $3.9m
- Jane Street Group LLCwas $1.5m
- D. E. Shaw & Co.was $1.2m
- Balyasny Asset Management LLCwas $994k
- Tudor Investment Corpwas $298k
- Hudson Bay Capital Management LPwas $208k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2026 | 2 | $56m | 12 | 0 |
| Q2 2026 | 2 | $93m | 9 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GENB and LLY →GENB and TMO →GENB and JNJ →Choose a stock to compare with GENB →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GENB, latest filings →Back to the 13F Explorer →